First Time Loading...

Invitae Corp
NYSE:NVTA

Watchlist Manager
Invitae Corp Logo
Invitae Corp
NYSE:NVTA
Watchlist
Price: 0.019 USD -35.59% Market Closed
Updated: Jul 21, 2024
Have any thoughts about
Invitae Corp?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Invitae Corp

Revenue
481.6m USD
Cost of Revenue
-350.9m USD
Gross Profit
130.7m USD
Operating Expenses
1.7B USD
Operating Income
1.8B USD
Other Expenses
-3.3B USD
Net Income
-1.4B USD

Margins Comparison
Invitae Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Invitae Corp
NYSE:NVTA
5.4m USD
27%
378%
-299%
US
Cigna Corp
NYSE:CI
95.4B USD
12%
5%
2%
US
Cigna Group
OTC:CI
96.1B USD
12%
5%
2%
US
CVS Health Corp
NYSE:CVS
74.6B USD
15%
4%
2%
DE
Fresenius Medical Care AG
XMUN:FME
21.5B EUR
25%
7%
2%
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.9B EUR
23%
6%
-1%
US
Labcorp Holdings Inc
OTC:LH
17.9B USD
28%
9%
4%
US
Laboratory Corporation of America Holdings
NYSE:LH
17.8B USD
28%
9%
4%
US
Quest Diagnostics Inc
NYSE:DGX
16.2B USD
33%
14%
9%
US
DaVita Inc
NYSE:DVA
12.1B USD
32%
14%
7%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.6B EUR
25%
7%
2%
Country US
Market Cap 5.4m USD
Gross Margin
27%
Operating Margin
378%
Net Margin
-299%
Country US
Market Cap 95.4B USD
Gross Margin
12%
Operating Margin
5%
Net Margin
2%
Country US
Market Cap 96.1B USD
Gross Margin
12%
Operating Margin
5%
Net Margin
2%
Country US
Market Cap 74.6B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Country DE
Market Cap 21.5B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
2%
Country DE
Market Cap 16.9B EUR
Gross Margin
23%
Operating Margin
6%
Net Margin
-1%
Country US
Market Cap 17.9B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
4%
Country US
Market Cap 17.8B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
4%
Country US
Market Cap 16.2B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 12.1B USD
Gross Margin
32%
Operating Margin
14%
Net Margin
7%
Country DE
Market Cap 10.6B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
2%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Invitae Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Invitae Corp
NYSE:NVTA
5.4m USD
312%
-112%
159%
214%
US
Cigna Corp
NYSE:CI
95.4B USD
8%
2%
9%
7%
US
Cigna Group
OTC:CI
96.1B USD
8%
2%
9%
7%
US
CVS Health Corp
NYSE:CVS
74.6B USD
10%
3%
8%
6%
DE
Fresenius Medical Care AG
XMUN:FME
21.5B EUR
3%
1%
5%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.9B EUR
-2%
-1%
4%
1%
US
Labcorp Holdings Inc
OTC:LH
17.9B USD
5%
2%
7%
4%
US
Laboratory Corporation of America Holdings
NYSE:LH
17.8B USD
5%
2%
7%
4%
US
Quest Diagnostics Inc
NYSE:DGX
16.2B USD
13%
6%
11%
8%
US
DaVita Inc
NYSE:DVA
12.1B USD
93%
5%
12%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.6B EUR
3%
1%
5%
3%
Country US
Market Cap 5.4m USD
ROE
312%
ROA
-112%
ROCE
159%
ROIC
214%
Country US
Market Cap 95.4B USD
ROE
8%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 96.1B USD
ROE
8%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 74.6B USD
ROE
10%
ROA
3%
ROCE
8%
ROIC
6%
Country DE
Market Cap 21.5B EUR
ROE
3%
ROA
1%
ROCE
5%
ROIC
3%
Country DE
Market Cap 16.9B EUR
ROE
-2%
ROA
-1%
ROCE
4%
ROIC
1%
Country US
Market Cap 17.9B USD
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country US
Market Cap 17.8B USD
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country US
Market Cap 16.2B USD
ROE
13%
ROA
6%
ROCE
11%
ROIC
8%
Country US
Market Cap 12.1B USD
ROE
93%
ROA
5%
ROCE
12%
ROIC
9%
Country DE
Market Cap 10.6B EUR
ROE
3%
ROA
1%
ROCE
5%
ROIC
3%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More